| Biogen Switzerland AG - Spinraza 12mg/5ml, Lösung zur intrathekalen Injektion |
| 66495 | | 01 | | Spinraza 12mg/5ml | | Lösung zur intrathekalen Injektion | | M09AX | | Andere Mittel gegen Störungen des Muskel- und Skelettsystems | | 20.09.2017 | | |
|
| Composition |
| Solvens: nusinersenum 12 mg ut nusinersenum natricum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas, natrii chloridum, kalii chloridum, calcii chloridum dihydricum, magnesii chloridum hexahydricum, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml. |
| Packungsbestandteile |
| Solvens | | | Lösung zur intrathekalen Injektion | | | | | | | | Principe actif | Concentr. |
|---|
| Nusinersenum | 12mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Nusinersenum | 12 mg |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum | | Calcii Chloridum Dihydricum | | Disodium Phosphate | | Potassium Chlorure | | Magnesium Chloride Hexahydrate | | Sodium Chlorure | | Sodium Dihydrogenophosphate Dihydrate | | Sodium Hydroxide |
| |
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 5 ml | 78390.18 | 80736.10 | A | LS | Non |
|
